Aberdeen Group plc Has $7.49 Million Stock Position in Tenet Healthcare Corporation $THC

Aberdeen Group plc trimmed its position in Tenet Healthcare Corporation (NYSE:THC) by 37.5% in the third quarter, Holdings Channel reports. The fund owned 37,237 shares of the company’s stock after selling 22,372 shares during the quarter. Aberdeen Group plc’s holdings in Tenet Healthcare were worth $7,492,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of THC. NewEdge Advisors LLC boosted its position in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp lifted its stake in shares of Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after acquiring an additional 1,274 shares during the period. Sivia Capital Partners LLC bought a new position in Tenet Healthcare during the second quarter worth $290,000. Chicago Partners Investment Group LLC acquired a new stake in Tenet Healthcare during the 2nd quarter worth about $273,000. Finally, Stephens Inc. AR bought a new position in shares of Tenet Healthcare in the 2nd quarter worth about $306,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This trade represents a 7.10% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.81% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on THC shares. UBS Group upped their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Raymond James Financial set a $245.00 price target on shares of Tenet Healthcare in a research report on Wednesday, October 29th. Barclays raised their price objective on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Cantor Fitzgerald lifted their target price on Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Finally, Wall Street Zen lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $247.67.

Tenet Healthcare Stock Up 0.6%

Shares of NYSE THC opened at $229.56 on Friday. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $235.77. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The company has a market cap of $19.96 billion, a P/E ratio of 14.82, a P/E/G ratio of 1.12 and a beta of 1.44. The business has a 50-day simple moving average of $201.87 and a two-hundred day simple moving average of $197.17.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same period last year, the firm posted $3.44 earnings per share. Tenet Healthcare’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.